Table 2.
Receptor | System | Stimulus | Manipulation | Effect on Neutrophil | Ref |
---|---|---|---|---|---|
unspecified | human neutrophil | fMLP | 2-chloroadenosine | inhibits adherence to endothelium | 29 |
unspecified | human neutrophil | fMLP | NECA | inhibits neutrophil-mediated endothelial damage | 29,44 |
unspecified | human neutrophil | fMLP | adenosine kinase inhibition | inhibits selectin-based adhesion | 47 |
unspecified | human neutrophil | fMLP | NECA | inhibits oxidative burst | 18,73 |
A1 | human neutrophil | fMLP | CPA | promotes chemotaxis | 9 |
A1 | human neutrophil | fMLP | CPA | promotes adhesion to gelatin-coated plates | 48 |
A1 | porcine neutrophil | PMA | COPA | promotes adhesion | 45 |
A1 | human neutrophil | antibody-coated erythrocytes | CPA | promotes FcRγ-mediated phagocytosis | 66,67 |
A1 | human neutrophil | FcRγ stimulation | CPA | enhances superoxide production | 66 |
A1, A2A/A2B | human neutrophil | LPS | COPA, CPCA | inhibits TNF release | 57 |
A2 | human neutrophil | complement C5, fMLP | NECA | promotes chemotaxis | 32 |
A2 | human neutrophil | fMLP | dipyrimidole, NECA | inhibits selectin shedding, expression of β2 integrins | 12,49 |
A2 | human neutrophil | fMLP | NECA | inhibits adhesion to fibrinogen-coated plates | 48 |
A2 | human neutrophil | antibody-coated yeast | NECA | inhibits FcRγ-mediated phagocytosis | 66,67 |
A2A | porcine neutrophil | PMA | NECA, CGS-21680 | inhibits adhesion | 45 |
A2A | canine neutrophil | PAF | CGS-21680 | inhibits adhesion | 46 |
A2A | human neutrophil | fMLP, TNF | ATL146e | inhibits adhesion to VCAM-1 coated surface | 50 |
A2A | canine neutrophil | myocardial infarction | ATL146e | inhibits p-selectin expression, infiltration | 52 |
A2A | murine neutrophil | carotid ligation | ATL146e | inhibits recruitment, integrin and selectin expression | 53 |
A2A | human neutrophil | LPS | CGS-21680 | inhibits inflammatory chemokine release | 58 |
A2A | Adora2a-/- mice | air pouch inflammation | - | inhibits COX-2 induction | 59 |
A2A | human neutrophil | fMLP | CGS-21680 | promotes COX-2, PGE2 generation | 59,60 |
A2A | whole blood, human neutrophil | fMLP | NECA, CGS-21680 | inhibits LTB4 synthesis | 61,62 |
A2A | human neutrophil | fMLP | CGS-21680 | inhibits leukotriene synthesis | 63 |
A2A | human neutrophil | various | CGS-21680 | inhibits LTA4 production | 64,65 |
A2A | rat neutrophil | meningitis | WRC-0470 | inhibits degranulation | 71 |
A2A | human, murine, rat neutrophil | fMLP, TNF, PAF, IgG, C3b-zymosan, bacterial meningitis | WRC-0470, CGS-21680, ATL193, ATL146e | inhibits oxidative burst | 70,75-79 |
A2A | human neutrophil | - | CGS-21680 | inhibits neutrophil apoptosis | 84,85 |
A2A, A3 | human neutrophil | fMLP, TNF, LPS | - | inhibits degranulation | 68-70 |
A2B | murine, human neutrophil | LPS, hypoxia, colitis | netrin-1 | inhibits recruitment, transepithelial migration | 39-41 |
A2B | murine neutrophil | fMLP | BAY 60-6583 | inhibits superoxide production | 83 |
A3 | human neutrophil | fMLP | - | promotes chemotaxis | 33 |
A3 | Adora3-/- mice | sepsis | - | inhibits recruitment | 34 |
A3 | canine, rabbit neutrophil | PAF | Cl-IB-MECA | inhibits adhesion to endothelium | 54 |
Abbreviations: N-formyl-methionine-leucine-phenylalanine (fMLP), Phorbol myristate acetate (PMA), lipopolysaccharide (LPS), platelet activating factor (PAF), prostaglandin (PG), arachadonic acid (AA), leukotriene (LT), lipoxygenase (LO). See Table 1 for ligand information.